Measuring 25-OH vitamin D levels is useful during menopause because declining estrogen accelerates bone loss, and vitamin D is critical for calcium absorption and bone health. Deficiency (<20 ng/mL) or insufficiency (20–30 ng/mL) increases osteoporosis risk. However, a blood test is the gold standard; DNA tests for VDR or other vitamin-D-related genes have small effect sizes and are not clinically actionable for dosing decisions. Evidence is based on clinical practice and observational studies (practice-level), not on robust genetic prediction. Supplementation should be guided by measured levels: typically 800–2000 IU/day, with higher doses only under medical supervision (max 4000 IU/day). MyBody-X's DNA test may offer background insights but cannot replace a blood test or clinical advice. Caveat: a single measurement is a snapshot; repeat testing and physician consultation are recommended for long-term management.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-044141eb89dc2683ddba6460